TREM2 and nonpapillary renal cell carcinoma: Similarly, TREM2, an established marker for post-surgical recurrence of ccRCC30, shows higher expression in a large proportion of the pro-tumour TAM and tissue-resident monocytes for patient HG_3 with recurrent ccRCC.